Clinical Study Grants
The British Heart Foundation Clinical Study Grants fund ambitious cardiovascular clinical trials and targeted studies designed to change patient care and clinical practice.
Browse similar grants
Funder: British Heart Foundation
Due Dates: January 14, 2026 (Full application, April 2026 committee) | July 1, 2026 (Full application, October 2026 committee) | August 27, 2026 (Preliminary application, September 2026 panel) | October 22, 2026 (Preliminary application, November 2026 panel) | February 11, 2027 (Preliminary application, March 2027 panel) | April 22, 2027 (Preliminary application, May 2027 panel) | January 13, 2027 (Full application, April 2027 committee) | August 26, 2027 (Preliminary application, September 2027 panel) | October 21, 2027 (Preliminary application, November 2027 panel)
Funding Amounts: No formal cap; awards typically over £500,000 or >4 years; funding based on project scale and ambition, with value for money assessed.
Summary: Supports ambitious, practice-changing cardiovascular clinical trials and targeted observational studies to improve patient care.
Key Information: Two-stage application: preliminary application required before full submission unless GCRFF-endorsed.
Description
The British Heart Foundation (BHF) Clinical Study Grants fund large-scale clinical trials and targeted observational studies focused on cardiovascular disease. These grants are intended for ambitious studies—usually costing more than £500,000 or lasting over four years—that address clearly defined clinical questions and have the potential to directly influence patient care or future clinical practice. Eligible projects include late-phase interventional trials (e.g., drugs, surgery, devices, care pathways) and hypothesis-led observational studies involving specific patient groups, typically within the NHS. The BHF encourages national or international collaboration, especially for practice-changing research. The scheme does not support open-ended epidemiological cohort studies or projects mainly focused on genetics/genomics; alternative BHF schemes are available for those areas.
